webinar register page

Webinar banner
NeoGenomics Lung Cancer Tumor Board
NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.

Each session, multidisciplinary teams will submit and discuss 2 - 4 patients with expert oncologists. For more information on this and our other tumor boards, please visit https://neogenomics.com/client-services/education/tumor-boards (copy and paste into browser).

Next Tumor Board: November 10th, 2021.
Look forward to dates coming soon for our 2022 series.

We look forward to having you join us. Please contact the Scientific Collaboration & Engagement team at tumorboards@neogenomics.com to inquire about submitting cases for review, or for any questions.
Nov 10, 2021 09:00 AM
Time shows in
Webinar logo
* Required information
Loading
Register

Speakers

Narjust Duma, MD
Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care @UWHealth
Dr. Narjust Duma is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. She is a medical oncologist with clinical and research focus on thoracic malignancies. She has been recognized for her work with numerous awards, including the Mayo Brothers Distinguished Fellowship Award, considered the highest trainee honor in the Mayo Clinic School of Graduate Medical Education; the Merit Award/ASCO Employees Endowed Merit Award, American Society of Clinical Oncology; and the Next-Generation Innovators Award, HemOnc Today - Healio, Scholar in Training Award, 11th American Association of Cancer Research (AACR) conference on the science of cancer health disparities in racial/ethnic minorities and the medically underserved. Dr. Duma's clinical interests include medical oncology with emphasis on thoracic cancer, including small cell and non-small cell lung cancer, thymic malignancies and mesothelioma.
Hutan Husain, MD
Associate Professor of Medicine @UC San Diego Health
Dr Husain is a board-certified medical oncologist who specializes in treating lung cancer and brain tumors. In addition to instructing medical students, residents and fellows, he is also a physician-scientist dedicated to understanding the cancer genome and how to advance meaningful, precision-oriented therapies for patients. Dr. Husain has developed a translational research focus and collaborates with scientists to bring discoveries from bench-to-bedside. His efforts include expanding tools for tracking cancer growth specifically through circulating tumor DNA analyses; understanding the mechanisms of cancer formation in non-smoking patients; and investigating how the genome can provide clues to optimal treatments and new therapies. He completed a fellowship in medical oncology at Johns Hopkins School of Medicine and a residency in internal medicine at Keck School of Medicine of USC. Dr. Husain earned his medical degree from Northwestern University Feinberg School of Medicine.

Share via Email

All fields are required
 

Switch Time Zone